Summary
Jinkuk Kim is an assistant professor at KAIST specializing in genomics and oligonucleotide therapies for rare neurogenetic disorders, with eight years of experience bridging computational biology and clinical translation. He earned his PhD in Bioinformatics and Integrative Genomics from the Harvard‑MIT HST program and trained on small regulatory RNAs at the Whitehead Institute with David Bartel. His work spans machine learning models that predict molecular phenotypes to patient‑customized antisense oligonucleotide therapies, notably contributing to a first‑in‑human NEJM case for Batten disease. Prior industry and hospital roles include Deep Genomics and Harvard Medical School/Boston Children’s Hospital, where he developed NGS‑based diagnostics and genetic therapies. He also has a track record in tumor genomics from his Samsung Medical Center research, linking radiographic and mutational evolution in recurrent brain tumors. Based in Daejeon, he leads a laboratory for computational biology and medicine that couples high‑throughput sequencing, ML, and rapid therapeutic design.
8 years of coding experience
6 years of employment as a software developer
Doctor of Philosophy (PhD), Harvard-MIT Division of Health Science and Technology, Bioinformatics and Integrative Genomics, Doctor of Philosophy (PhD), Harvard-MIT Division of Health Science and Technology, Bioinformatics and Integrative Genomics at Massachusetts Institute of Technology
Seoul Science High School
Bachelor of Science (BS), Computer Science (minor: Biology), Bachelor of Science (BS), Computer Science (minor: Biology) at Korea Advanced Institute of Science and Technology